The influence of the progression of secondary hyperparathyroidism on the set point of the parathyroid hormone-calcium curve

Journal of Endocrinology

Volumn 184, Issue 1, 2005, Pages 241-247

  Bas, S ^b   Aguilera Tejero, E ^b   Bas, A ^b   Estepa, J C ^b   Lopez, I ^b   Madueno J A ^a   Rodriguez, M ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALCIUM RECEPTOR; MESSENGER RNA; PARATHYROID HORMONE; RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR SPACE; FEMALE; HYPOCALCEMIA; KIDNEY FAILURE; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SECONDARY HYPERPARATHYROIDISM;

ANIMALS; CALCITRIOL; CALCIUM; CREATININE; DISEASE PROGRESSION; EXTRACELLULAR SPACE; FEMALE; HYPERPARATHYROIDISM, SECONDARY; MALE; NEPHRECTOMY; PARATHYROID GLANDS; PARATHYROID HORMONE; PHOSPHATES; RABBITS; RECEPTORS, CALCITRIOL; RECEPTORS, CALCIUM-SENSING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE;

EID: 13444302265     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05565     Document Type: Article

References (30)

1. Aguilera-Tejero E, Sanchez J, Almaden Y, Mayer-Valor R, Rodriguez M & Felsenfeld AJ 1996 Hysteresis of the PTH-calcium curve during hypocalcemia in the dog: effect of the rate and linearity of calcium decrease and sequential episodes of hypocalcemia. Journal of Bone and Mineral Research 11 1226-1233.
2. Bas S, Aguilera-Tejero E, Estepa JC, Garfia B, Lopez I & Rodriguez M 2002 The influence of acute and chronic hypercalcemia on the parathyroid hormone response to hypocalcemia in rabbits. European Journal of Endocrinology 146 411-418.
3. Bas S, Bas A, Almaden Y, Ballesteros E, Rodriguez M & Aguilera-Tejero E 2003 Both duration and degree of hypercalcemia influence the reduced parathyroid hormone response to hypocalcemia after hypercalcemia. Journal of Endocrinology 177 119-126.
4. Bas S, Bas A, Estepa JC, Mayer-Valor R, Rodriguez M & Aguilera-Tejero E 2004 Parathyroid gland function in the uremic rabbit. Domestic Animal Endocrinology 26 99-110.
5. Borrego MJ, Felsenfeld AJ, Martin-Malo A, Almaden Y, Concepcion MT, Aljama P & Rodriguez M 1997 Evidence for adaptation of the entire PTH-calcium curve to sustained changes in the serum calcium in hemodialysis patients. Nephrology Dialysis and Transplantation 12 505-513.
6. Brown EM, Broadus AE, Brennan MF, Gardner DG, Marx SJ, Spiegel AM, Downs RW, Attie M & Aurbach GD 1979 Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 48 604-610.
7. Brown EM, Wilkson RE, Eastman RC, Pallota J & Marynick SP 1982 Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. Journal of Clinical Endocrinology and Metabolism 54 172-179.
8. Canalejo A, Almaden Y, Torregrosa V, Gomez-Villamandos JC, Ramos B, Campistol JM, Felsenfeld AJ & Rodriguez M 2000 The in vitro effect of calcitriol on parathyroid cell proliferation and apoptosis. Journal of the American Society of Nephrology 10 1865-1872.
9. Cardinal H, Brossard J-H, Roy L, Lepage R, Rousseau L & D'Amour P 1998 The set point of parathyroid hormone stimulation by calcium is normal in progressive renal failure. Journal of Clinical Endocrinology and Metabolism 83 3839-3844.
10. Carling T, Rastad J, Szabo E, Westin G & Akerstrom G 2000 Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 85 2000-2003.
11. 2+ set-point in patients with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 85 4789-4794.
12. Cloutier M, Gascon-Barre M & D'Amour P 1992 Chronic adaptation of dog parathyroid function to a low-calcium-high sodium-vitamin D-deficient diet. Journal of Bone and Mineral Research 7 1021-1027.
13. Felsenfeld AJ & Llach F 1993 Parathyroid gland function in chronic renal failure. Kidney International 43 771-789.
14. Fukuda N, Tanaka H, Tominaga Y, Fukugawa M, Kurokawa K & Seino Y 1993 Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. Journal of Clinical Investigation 92 1436-1443.
15. Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E & Drueke TB 1997 Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney International 51 328-336.
16. Goodman WG, Belin T, Gales B, Juppner H, Segre GV & Salusky IB 1995 Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism. Kidney International 48 1553-1558.
17. Goodman WG, Veldhuis JD, Belin TR, Van Herle AJ, Juppner H & Salusky IB 1998 Calcium-sensing by parathyroid glands in secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 83 2765-2772.
18. Hardy-Yverneau P, Shenouda M, Moriniere P, Legallais C, Brazier M, Achard J & Fournier A 1998 The dependency of calcium set point on basal plasma calcium in dialysis patients: a better explanation for the discrepancies regarding its link with PTH secretion than methodological differences. Clinical Nephrology 50 236-246.
19. Hernandez A, Concepcion MT, Rodriguez M, Salido E & Torres A 1996 High phosphorus diet increases preproPTH mRNA independent of calcium and calcitriol in normal rats. Kidney International 50 1872-1878.
20. Lewin E, Garfia B, Recio FL, Rodriguez M & Olgaard K 2002 Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by isogenic kidney transplantation. Journal of the American Society of Nephrology 13 2110-2116.
21. Malberti F, Corradi B, Pagliari, Romanini D, Gazo A, Sidoti A, Baretta A, Bellazi R & Imbasciati E 1993 The sigmoidal parathyroid hormone-ionized calcium curve and the set point of calcium in hemodialysis and continuous ambulatory peritoneal dialysis. Peritoneal Dialysis International 13 (Suppl 2) S476-S479.
22. Malberti F, Farina M & Imbasciati E 1999 The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism. Nephrology Dialysis and Transplantation 14 2398-2406.
23. Pahl M, Jara, A, Bover J, Rodriguez M & Felsenfield AJ 1996 The set point of calcium and the reduction of parathyroid hormone in hemodialysis patients. Kidney International 49 226-231.
24. Ramirez JA, Goodman WG, Gornbein J, Menezes C, Moulton L, Segre GV & Salusky IB 1993 Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 76 1489-1494.
25. Ritter CS, Finch JL, Slatopolsky EA & Brown AJ 2001 Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney International 60 1737-1744.
26. Rodriguez M, Caravaca F, Fernandez E, Borrego MJ, Lorenzo V, Cubero J, Martin-Malo A, Betriu A, Rodriguez AP & Felsenfeld AJ 1997 Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism. Journal of Bone and Mineral Research 12 347-355.
27. Silver J, Kilav R & Naveh-Many T 2002 Mechanisms of secondary hyperparathyroidism. American Journal of Physiology 283 F367-F376.
28. Szabo A, Ritz E, Schmidt-Gayk H & Reichel H 1996 Abnormal expression and regulation of vitamin D receptor in experimental uremia. Nephron 73 619-628.
29. Valimaki S, Farnebo F, Forsberg L, Larsson C & Farnebo LO 2001 Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism. Kidney International 60 1666-1675.
30. Warren HB, Lausen NCC, Segre GV, El-Hajj G & Brown EM 1989 Regulation of calciotropic hormones in vivo in the New Zealand White rabbit. Endocrinology 125 2683-2690.